GET THE APP

Temporal precision in hypertension care: A focus on chronomodulated drug delivery.

Asian Journal of Pharmaceutical Technology and Innovation (ajpti)

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective- Asian Journal of Pharmaceutical Technology and Innovation(2023)

Temporal precision in hypertension care: A focus on chronomodulated drug delivery.

Martha F. Douglass*
 
School of Pharmacy, University College London, London, United Kingdom
 
*Corresponding Author:
Martha F. Douglass, School of Pharmacy, University College London, London, United Kingdom, Email: Doulassmarthaf@uclsp.uk

Received: 17-Nov-2023, Manuscript No. AJPTI-23-123672; Editor assigned: 20-Nov-2023, Pre QC No. AJPTI-23-123672 (PQ); Reviewed: 04-Dec-2023, QC No. AJPTI-23-123672; Revised: 11-Dec-2023, Manuscript No. AJPTI-23-123672 (R); Published: 18-Dec-2023

Description

This potential of chronomodulated drug delivery systems as innovative approaches for the treatment of hypertension. Hypertension, a prevalent cardiovascular disorder, exhibits rhythmic patterns in its pathophysiology. Recognizing the importance of circadian rhythms in blood pressure regulation, chronomodulated drug delivery systems aim to optimize therapeutic outcomes by aligning drug administration with the body's natural physiological rhythms. This review discusses the chronobiology of hypertension, the rationale behind chronomodulated drug delivery, and current advancements in the development of such systems for hypertension management.

Chronomodulated drug delivery systems represent a groundbreaking paradigm in drug delivery, acknowledging the inherent circadian rhythms governing physiological processes. The concept, principles, and recent advancements in chronomodulated drug delivery systems. Emphasizing the potential for improved therapeutic outcomes and reduced side effects, we explore the applications of these systems across various medical fields and the challenges and opportunities associated with their implementation.

Hypertension, characterized by sustained elevation of blood pressure, is a major risk factor for cardiovascular diseases and remains a global health concern. The circadian variation in blood pressure, with higher levels during the day and lower levels at night, highlights the importance of circadian rhythms in the pathophysiology of hypertension. Chronomodulated drug delivery systems, designed to release medications at specific times to synchronize with circadian rhythms, present an innovative approach for optimizing the treatment of hypertension.

The human body exhibits circadian variations in blood pressure, influenced by the intrinsic circadian clock and external factors such as sleep-wake cycles and daily activities. Blood pressure typically follows a pattern of higher levels during waking hours and lower levels during sleep. Dysregulation of these rhythms is commonly observed in individuals with hypertension.

Chronopharmacology recognizes the impact of circadian rhythms on drug pharmacokinetics and pharmacodynamics. Medications administered at specific times may achieve enhanced efficacy and reduced side effects. Understanding the chronobiology of hypertension is crucial for tailoring drug delivery systems that optimize therapeutic outcomes. Chronomodulated drug delivery systems for hypertension often involve oral formulations designed to release the medication at specific times. These formulations may include pulsatile release systems, where the drug is released in bursts to coincide with peak blood pressure periods.

Transdermal patches with chronomodulated drug release profiles offer an alternative approach. These systems can provide a sustained release of antihypertensive medications, aligning with the circadian variation in blood pressure. The skin's ability to absorb medications allows for a controlled and continuous delivery throughout the day.

Implantable devices, such as micropumps or osmotic pumps, enable precise control over drug release. These systems can be programmed to release medications at specific intervals, optimizing the timing of drug delivery based on the patient's circadian rhythms.

Recent advancements incorporate smart technologies, such as microsensors and feedback mechanisms, to dynamically adjust drug release based on real-time physiological parameters. This personalized approach aims to optimize antihypertensive therapy by adapting to individual variations in circadian rhythms.

The development of biocompatible materials enhances the safety and longevity of chronomodulated drug delivery systems. Encapsulation technologies and polymeric materials ensure the controlled release of medications while minimizing adverse reactions.

Integrating patient-friendly features, such as user-friendly interfaces and minimal maintenance requirements, addresses challenges related to patient adherence. Improving convenience and reducing the burden on patients contribute to the success of chronomodulated drug delivery systems.

Chronomodulated drug delivery systems represent a promising avenue for optimizing the treatment of hypertension by aligning medication administration with the body's circadian rhythms. Understanding the chronobiology of hypertension and leveraging advancements in drug delivery technologies contribute to the development of innovative therapeutic strategies. Further research is needed to evaluate the clinical efficacy, safety, and long-term outcomes of chronomodulated drug delivery systems in managing hypertension. As these technologies evolve, they hold the potential to revolutionize hypertension management by providing personalized and effective treatment options.

Citation: Douglass MF. Temporal precision in hypertension care: A focus on chronomodulated drug delivery. AJPTI 2023;11 (45):1.